OptimizeRx Corporation Common Stock (OPRX) Stock Price
OPRXStock
$8.50−57.03%52W
Market Cap$160.11M
P/E31.20x
PEG Ratio1.61
Div yield—
Beta1.18
OPRX Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)30.59%
Price vs S&P 500 (4W)13.76%
PEG Ratio1.61
VGM Score54.10
P/E Ratio (Annual)31.20x
OPRX Earnings Surprise History
| Quarter | Report date | EPS estimate | EPS actual | Surprise |
|---|---|---|---|---|
| Q2 2026 | $0.11 | $0.16 | +42.86%(+$0.05) | |
| Q4 2025 | $0.22 | $0.51 | +127.38%(+$0.29) | |
| Q3 2025 | $0.04 | $0.20 | +438.50%(+$0.16) | |
| Q2 2025 | $0.02 | $0.24 | +1300.23%(+$0.22) |
OPRX Analyst Recommendations
Jun 2026
Jul 2026
Aug 2026
Sep 2026
4.15
4.25
4.25
4.25
Industry Peers — Business Services(124)
| Symbol | Value Score | Growth Score | Momentum Score | P/E Ratio (Annual) | Revenue Growth (5Y) | Operating Margin (TTM) | ROE (TTM) | Price |
|---|---|---|---|---|---|---|---|---|
OPRXOptimizeRx Corporation Common Stock | B | D | B | 31.2x | 20.4% | 11.1% | 3.6% | $8.50 |
| VVISA Inc. | F | C | B | 37.5x | 12.9% | 60.7% | 61.3% | $402.61 |
| MAMastercard Incorporated | F | B | B | 36.1x | 16.5% | 58.3% | 232.5% | $617.42 |
| QHQuhuo Limited Class A Ordinary Shares | B | F | C | 98.9x | -0.4% | -7.0% | -39.0% | $3.35 |
| BABAAlibaba Group Holding Limited American Depositary Shares, each represents eight Ordinary Shares | C | D | C | 17.0x | 7.4% | 2.9% | 7.0% | $109.11 |
| UBERUber Technologies, Inc. | C | B | C | 14.3x | 36.1% | 12.1% | 35.7% | $70.35 |
| ACNAccenture PLC | C | C | A | 16.8x | 8.0% | 15.4% | 26.7% | $229.68 |
| PDDPDD Holdings Inc. American Depositary Shares | B | C | C | 8.0x | 48.6% | 21.9% | 22.0% | $80.97 |
| MELIMercado Libre, Inc | C | B | C | 46.6x | 48.7% | 8.3% | 26.5% | $1834.00 |
| DASHDoorDash, Inc. Class A Common Stock | F | B | C | 87.7x | 36.6% | 4.5% | 8.5% | $189.15 |
| RELXRELX PLC | D | C | B | 24.3x | 6.2% | 32.6% | 125.5% | $39.06 |
About OptimizeRx Corporation Common Stock
OptimizeRx provides a cloud-based digital health messaging platform integrated with electronic health records that enables pharmaceutical companies to communicate directly with healthcare providers and patients. The platform supports medication adherence through real-time access to financial assistance, prior authorization, clinical information, and patient education. Its product suite includes Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.